# Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer

> **NCT01918527** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Vejle Hospital** · enrollment: 250 (actual)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** Capecitabine
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT01918527
- **Lead sponsor:** Vejle Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-09
- **Primary completion:** 2023-06
- **Final completion:** 2026-06
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01918527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01918527, "Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01918527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*